EORTC protocol 22085 - 10083

A randomized phase III study of radiation doses and fractionation schedules for ductal carcinoma in situ (DCIS) of the breast.
Trial StatusRecruiting
DatesDate of activation: 18-Jan-10
Data management at EORTCMailbox
Phase3
Randomized trialYes
TypeAdjuvant
Targeted Sample sizeEORTC Groups: 400 - All Groups: 610
Number of steps1
Drug
Study StaffHelen Westenberg (Study Coordinator) - Arnhem's Radiotherapeutisch Instituut, Arnhem
Laurence Collette (Statistician) - EORTC Headquarters, Brussels
Livia Giurgea (Data Manager) - EORTC Headquarters, Brussels
Denis Lacombe (Coordinating Physician) - EORTC Headquarters, Brussels
Emad Shash (Coordinating Physician) - EORTC Headquarters, Brussels
Julie Hermans (Project Manager) - EORTC Headquarters, Brussels, julie.hermans( at )eortc.be, +32 27741673
Type of cancerBreast
Participating GroupsTrans-Tasman Radiation Oncology Group Inc(Coordinating Group)
EORTC Breast Cancer Group
EORTC Radiation Oncology Group
Borstkanker Onderzoeksgroup Nederland
Centers authorized by EORTC Hôpitaux Universitaires Bordet-Erasme - Institut Jules Bordet (Brussels, Belgium) - Inst. 101
ZNA Middelheim (Antwerpen, Belgium) - Inst. 114
Cliniques Universitaires St. Luc (Brussels, Belgium) - Inst. 121
Universitair Ziekenhuis Brussel (Brussels, Belgium) - Inst. 128
Onze Lieve Vrouw Ziekenhuis (Aalst, Belgium) - Inst. 150
Hopital De Jolimont (Haine St Paul, Belgium) - Inst. 474
Algemeen Ziekenhuis Sint-Augustinus (Wilrijk, Belgium) - Inst. 1234
AZ Groeninge Kortrijk - Campus Loofstraat (Kortrijk, Belgium) - Inst. 1257
CHU de Grenoble - La Tronche - Hôpital A. Michallon (Grenoble, France) - Inst. 215
Centre Antoine Lacassagne (Nice, France) - Inst. 218
The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis (Amsterdam, The Netherlands) - Inst. 301
Leiden University Medical Centre (Leiden, The Netherlands) - Inst. 310
Medisch Centrum Haaglanden - Westeinde (Den Haag, The Netherlands) - Inst. 311
Isala Klinieken - Locatie Weezenlanden (Zwolle, The Netherlands) - Inst. 329
University Medical Center Groningen (Groningen, The Netherlands) - Inst. 335
Academisch Medisch Centrum - Universiteit van Amsterdam (Amsterdam, The Netherlands) - Inst. 342
Arnhem's Radiotherapeutisch Instituut (Arnhem, The Netherlands) - Inst. 350
Maastro Clinic - Maastricht Radiation Oncology (Maastricht, The Netherlands) - Inst. 4900
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT numberNCT00470236
EudraCT
Protocol documents in PDF
(requires password)
Study documentation
Back to Protocol section